Search Results

Results 1–20 of 79
Sort By: Relevance| Date| Title

1.
February 2018

Members Only


Practice Bulletin Number 189, January 2018

(Replaces Practice Bulletin 153, September 2015)

Members Only


Practice Bulletin Number 188, January 2018

(Replaces Practice Bulletin Number 172, October 2016)

Members Only


4.
December 2017

Practice Bulletin Number 187, December 2017

(Replaces Practice Bulletin Number 44, July 2003)

Members Only


Practice Bulletin Number 186, November 2017

(Replaces Practice Bulletin Number 121, July 2011)

Intrauterine devices and contraceptive implants, also called long-acting reversible contraceptives (LARC), are the most effective reversible contraceptive methods. The major advantage of LARC compared with other reversible contraceptive methods is that they do not require ongoing effort on the part of the patient for long-term and effective use. In addition, after the device is removed, the return of fertility is rapid (1, 2). The purpose of this Practice Bulletin is to provide information for appropriate patient selection and evidence-based recommendations for LARC initiation and management....


6.
November 2017

Practice Bulletin Number 185, November 2017

(Replaces Practice Bulletin Number 176, April 2017)

Members Only


Practice Bulletin Number 184, November 2017

(Replaces Practice Bulletin Number 115, August 2010)

Members Only


8.
October 2017

Practice Bulletin Number 183, October 2017

(Replaces Practice Bulletin Number 76, October 2006)

Members Only


Practice Bulletin Number 182, September 2017

(Replaces Practice Bulletin Number 103, April 2009)

Members Only


Practice Bulletin Number 181, August 2017

(Replaces Practice Bulletin Number 4, May 1999)

Members Only


Practice Bulletin Number 180, July 2017

(Replaces Practice Bulletin Number 137, August 2013)

Members Only


Practice Bulletin Number 179, July 2017

(Replaces Practice Bulletin Number 122, August 2011)

Breast cancer is the most commonly diagnosed cancer in women in the United States and the second leading cause of cancer death in American women (1). Regular screening mammography starting at age 40 years reduces breast cancer mortality in average-risk women (2). Screening, however, also exposes women to harm through false-positive test results and overdiagnosis of biologically indolent lesions. Differences in balancing benefits and harms have led to differences among major guidelines about what age to start, what age to stop, and how frequently to recommend mammography screening in average-r...


13.
May 2017

Practice Bulletin Number 178, May 2017

(Replaces Practice Bulletin Number 40, November 2002)

Members Only


Practice Bulletin Number 177, April 2017

(Replaces Practice Bulletin Number 36, July 2002; Committee Opinion
Number 295, July 2004; Committee Opinion Number 339, June 2006;
and Committee Opinion Number 376, August 2007)

Members Only


15.
December 2016

Practice Bulletin Number 175, December 2016

(Replaces Practice Bulletin Number 101, February 2009, and Committee Opinion 297, August 2004)

Members Only


Practice Bulletin Number 174, November 2016

(Replaces Practice Bulletin Number 83, July 2007)

Members Only


17.
November 2016

Practice Bulletin Number 173, November 2016

(Replaces Practice Bulletin Number 22, November 2000)

Members Only


18.
October 2016

Practice Bulletin Number 171, October 2016

(Replaces Practice Bulletin Number 159, January 2016)

Members Only


19.
October 2016

Practice Bulletin Number 170, October 2016

(Replaces Practice Bulletin Number 158, January 2016) (Reaffirmed 2017)

Members Only


Practice Bulletin Number 169, October 2016

(Replaces Practice Bulletin Number 144, May 2014) Reaffirmed 2016

Members Only


Advertisement

American College of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998